SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICN Pharmaceuticals
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Young who wrote (989)10/29/1999 5:01:00 PM
From: Bret Masterson  Read Replies (1) of 1029
 
(1) Yes, hopefully this earnings report is clean, and w/out surprises. ICN really needs just a few quarters of consistent growth with no major write-offs or surprises and we could easily be looking at $40/share early next year.

(2) My feeling is that a strong report now gets us back to $30, and if ICN can follow up with a good 4th Qrt, then we might get back up near $40/share.

(3) $1+ gain today maybe a signal of good things to come.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News